Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EXTEDO is a global provider of Regulatory Information Management (RIM) solutions tailored for the life sciences industry. The company offers a comprehensive suite of software and services designed to manage the entire product lifecycle, from development to post-market surveillance. Key products include eCTDmanager for submission management and EURS for regulatory review, which are utilized by both commercial enterprises and national health authorities. By streamlining regulatory workflows and ensuring compliance with global standards, EXTEDO helps organizations reduce risk and accelerate the delivery of new medicines. In early 2024, EXTEDO was acquired by ArisGlobal, a move that integrated their RIM capabilities into a broader end-to-end drug development platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EXTEDO.